# OnCo record ipsen (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/ipsen/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "ipsen" ;
  schema:name "Ipsen"@en ;
  schema:description "Ipsen is the French pharma behind Onivyde (liposomal irinotecan) and the NALIRIFOX regimen, and marketer of tovorafenib in Europe."@en ;
  schema:url <https://onco.cc/companies/ipsen/>, <https://www.ipsen.com> ;
  schema:dateModified "2026-09-06"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Ipsen> ;
  owl:sameAs <http://www.wikidata.org/entity/Q111546> ;
  schema:citation <https://www.ipsen.com> ;
  schema:addressCountry "FR" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/glioblastoma/> ;
  onco:drugs <https://onco.cc/drugs/nalirifox/>, <https://onco.cc/drugs/tovorafenib/> ;
  onco:trials <https://onco.cc/trials/nct04224493/>, <https://onco.cc/trials/nct07213830/>, <https://onco.cc/trials/nct07213817/>, <https://onco.cc/trials/nct06833008/>, <https://onco.cc/trials/nct06305247/>, <https://onco.cc/trials/nct04243499/> .